Use of progestational agents in endometrial adenocarcinoma.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality; D000284:Administration, Oral; D004717:Endometrium / Q000187:drug effects; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008524:Medrogestone / Q000008:administration & dosage / Q000627:therapeutic use; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000627:therapeutic use; D008535:Megestrol / Q000008:administration & dosage / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D011372:Progestins / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000401:mortality
D011372:Progestins; D008524:Medrogestone; D008535:Megestrol; D008525:Medroxyprogesterone